Second-line chemotherapy with capecitabine (Xeloda) and docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial.

导出 LinkOut

翻译打印收藏纠错

作者： Ourania,Katopodis ^[1] ; Aris,Polyzos ; Nikolaos,Kentepozidis ; Stylianos,Giassas ; Maria,Rovithi ; Vasiliki,Bozionelou ; Kostas,Kalbakis ; Lambros,Vamvakas ; Dimitris,Mavroudis ; Vassilis,Georgoulias

作者单位： Hellenic Oncology Research Group (HORG), 55 Lombardou str., 11470 Athens, Greece. ^[1]

主题词腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);脱氧胞苷(Deoxycytidine);无病生存(Disease-Free Survival);女(雌)性(Female);氟尿嘧啶(Fluorouracil);人类(Humans);男(雄)性(Male);中年人(Middle Aged);胰腺肿瘤(Pancreatic Neoplasms);生活质量(Quality of Life);存活率(Survival Rate);紫杉烷类(Taxoids);治疗结果(Treatment Outcome)

DOI 10.1007/s00280-010-1329-6

PMID 20428874

发布时间 2018-12-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览9

Cancer chemotherapy and pharmacology

2011年67卷2期

361-8页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Second-line chemotherapy with capecitabine (Xeloda) and docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial.

Cancer chemotherapy and pharmacology

相似文献

Cancer chemotherapy and pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Second-line chemotherapy with capecitabine (Xeloda) and docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial.

Cancer chemotherapy and pharmacology

相似文献

Cancer chemotherapy and pharmacology

相关期刊

检索历史清除